BNP Paribas has strengthened its shareholding in Grifols in the midst of the stock market storm that has hit the company since the beginning of the year due to the Gotham City Research report. The French bank has raised a 3.051% stake, which at the current market price is valued at €140 million, through the BNP Paribas Asset Management Europe vehicle.
The financial institution acquired the shares on March 13, when the securities were trading at over eight euros. The CNMV records do not include the volume of shares acquired because BNP Paribas was not obliged to declare its initial position as it did not exceed the limit set by law of 3%.
One day after the operation, the shares sank to almost seven euros after the publication of the Standard reports
In recent months, several institutional investors have taken advantage of the bad moment that the multinational blood products company is going through on the stock market to reinforce their capital. This is the case of JP Morgan (3.8%), Melqart Opportunities Master Fund (1.12%) or BlackRock (4.3%).
